Electronic Health Data Could Boost Chronic Disease Surveillance

Accurate and timely information plays a crucial role in maintaining public health. As the recent coronavirus pandemic showed, securing the right information as early as possible can allow for the creation of preventative and mitigation strategies. Even though the worst of the pandemic is now behind us, some lessons we learned, such as the value of transmitting electronic health records (EHR) to public health agencies, will still be significant moving forward.

NYU Grossman School of Medicine’s Lorna Thorpe, PhD, and Brian Dixon, PhD, MPA, from Indiana University Richard M. Fairbanks School of Public Health and the Regenstrief Institute, will talk about the significance of EHR at the upcoming HIMMS Global Health Conference & Exhibition.

While the primary reason for entering patient information into electronic records is to track their treatment and health, this information has greater significance. Dixon says that electronic health records can also be used for public health purposes, especially tracking new cases of conditions such as hypertension and diabetes. This data can also help to calculate the rates at which hypertension and diabetes are affecting the population, he noted.

Electronic health records are also integral to tracking chronic diseases because they allow for the analysis of data from smaller geographic regions. Dixon explains that this helps physicians come up with custom interventions for chronic conditions that affect specific regions. He says that with everything we have learned due to the coronavirus pandemic, we have what it takes to develop infrastructure that would allow us to predict future pandemics while supporting public health endeavors like ‘monitoring the burden of chronic illness.’

Dixon and Thorpe will discuss using electronic health data to raise the level of health care for patients with chronic conditions such as diabetes. They will also talk about leveraging EHR data to help patients manage their chronic conditions better and more effectively. The two speakers will specifically focus on long COVID, cardiovascular disease, and diabetes and how to use EHR data to optimize the measurement of chronic disease burden. This will include integration and interoperability requirements and the benefits of using both clinical and administrative data.

Long COVID is a medical phenomenon that occurred a few months into the pandemic. It is characterized by sustained COVID symptoms lasting from three months up to two years after infection.

Thorpe and Dixon will present at the HIMSS23 conference, an event expected to attract 40,000 professionals from across the worldwide health ecosystem.

Health service organizations such as Progressive Care Inc. (OTCQB: RXMD) have a significant role to play to enable health data to help policymakers have a clearer picture of how diseases break out and spread in different sections of the global population.

NOTE TO INVESTORS: The latest news and updates relating to Progressive Care Inc. (OTCQB: RXMD) are available in the company’s newsroom at https://ibn.fm/RXMD

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.